Board Meeting31 Jul 2026, 01:57 pm
Ishita Drugs Board Meeting on Aug 8 to Review Q1 FY27 Results
AI Summary
Ishita Drugs & Industries Ltd has announced that its Board of Directors will convene on August 8, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter ended June 30, 2026. Additionally, the meeting will address any other business with the chair's permission. In line with SEBI regulations, the trading window for designated persons will remain closed from July 1, 2026, until 48 hours after the announcement of these financial results.
Key Highlights
- Board meeting scheduled for August 8, 2026.
- To approve unaudited financial results for Q1 FY27.
- Trading window closure announced until results disclosure.
- Compliance with SEBI (Prohibition of Insider Trading) Regulations.
Price Impact
More from ISHITADR